Manufacturer record
Eurokem Laboratories Pvt ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
10 batches manufactured by Eurokem Laboratories Pvt ltd (Tamil Nadu) were declared Not of Standard Quality between October 2019 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AT26036, Atorvastatin Tablets IP 10mg (exp Aug 2027). DTL, Chennai-06 (state lab) found it not of standard quality: Dissolution. Listed in the August 2026 alert.
Records by type
10 records linked to Eurokem Laboratories Pvt ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Atorvastatin Tablets IP 10mg | Batch AT26036Mfg Mar 2026 · Exp Aug 2027 | DissolutionDissolution | DTL, Chennai-06State lab | Aug 2026 |
| Atorvastatin Tablets IP 10mg | Batch AV26072Mfg Apr 2026 · Exp Sep 2027 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Atorvastatin Tablets IP 10mg | Batch AC25002Mfg May 2025 · Exp Apr 2027 | The Sample does not meets the Specifications wrt. Dissolution Test as per IP.Dissolution | State Lab, DCL, TelanganaState lab | Jun 2026 |
| Telmisartan Tablets IP 40mg | Batch TS24047Mfg Oct 2024 · Exp Dec 2025 | Dissolution of Telmisartan TabletsDissolution | CDTL ChennaiCDSCO lab | Jun 2025 |
| Telmisartan Tablets IP 40mg | Batch TS24042Mfg Oct 2024 · Exp Dec 2025 | Dissolution of Telmisartan TabletsDissolution | CDTL ChennaiCDSCO lab | Jun 2025 |
| Aceclofenac Tablets IP 100mg | Batch AF24009Mfg Sep 2024 · Exp Aug 2026 | Content of AceclofenacOther | DTL MaduraiState lab | Jun 2025 |
| Nifedipine Sustained Release Tablets IP 10 mg | Batch NF24007Mfg Aug 2024 · Exp Jan 2026 | Sample does not conform to IP specification for Nifedipine Sustained Release Tablets with respect to the content of NifedipineOther | Drugs Testing Laboratory, Madurai-19State lab | May 2025 |
| Atorvastatin Tablets IP 10mg | Batch AT24045Mfg Aug 2024 · Exp Jan 2026 | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab | Apr 2025 |
| Glimepiride Tablets I.P. 1mg | Batch GP108Mfg Apr 2021 · Exp Mar 2023 | Dissolution & Related SubstancesDissolution | CDL KolkataCDSCO lab | Nov 2021 |
| Levodopa & Carbidopa Tablets IP | Batch AU49Mfg Dec 2018 · Exp Nov 2020 | Description & Assay of Levodopa & CarbidopaAssay | CDTL ChennaiCDSCO lab | Oct 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.